(Q34252230)

31 July 2017

MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma (English)

1 reference

31 July 2017

0 references

Honglin Zhu

1

1 reference

31 July 2017

Yisha Li

2

1 reference

31 July 2017

Shunlin Qu

3

1 reference

31 July 2017

Hui Luo

4

1 reference

31 July 2017

Yaou Zhou

5

1 reference

31 July 2017

Yanping Wang

6

1 reference

31 July 2017

Hongjun Zhao

7

1 reference

31 July 2017

Yunhui You

8

1 reference

31 July 2017

Xianzhong Xiao

9

1 reference

31 July 2017

Xiaoxia Zuo

10

1 reference

31 July 2017

4 February 2012

1 reference

Journal of Clinical Immunology

31 July 2017

1 reference

31 July 2017

32

1 reference

31 July 2017

3

1 reference

31 July 2017

514-522

1 reference

https://scigraph.springernature.com/pub.10.1007/s10875-011-9647-y

31 July 2017

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9647-Y

Systemic sclerosis: a prototypic multisystem fibrotic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9647-Y

Role of transforming growth factor beta in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9647-Y

Dysregulation of transforming growth factor beta signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9647-Y

Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9647-Y

Physiological and pathological roles for microRNAs in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9647-Y

Small non-coding RNAs in animal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9647-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9647-Y

MicroRNAs and the regulation of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9647-Y

MicroRNA-29, a key regulator of collagen expression in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9647-Y

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9647-Y

A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9647-Y

Cellular and molecular mechanisms of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9647-Y

Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9647-Y

Toward microRNA-based therapeutics for heart disease: the sense in antisense

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9647-Y

LNA-mediated microRNA silencing in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9647-Y

Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9647-Y

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9647-Y

Immunohistological demonstration of transforming growth factor-beta isoforms in the skin of patients with systemic sclerosis

21 January 2018

1 reference

12 December 2020

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

12 December 2020

Circulating miR-29a levels in patients with scleroderma spectrum disorder

1 reference

12 December 2020

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

1 reference

12 December 2020

MicroRNA array analysis of microRNAs related to systemic scleroderma.

1 reference

12 December 2020

Immunohistochemical localization of intracellular and extracellular associated TGF beta in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon

1 reference

12 December 2020

Fibronectin release by systemic sclerosis and normal dermal fibroblasts in response to TGF-beta

1 reference

12 December 2020

10.1007/S10875-011-9647-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference